"The progression of elecoglipron is an important step in delivering a differentiated weight management portfolio, offering monotherapies and combinations, designed to address the biological complexity of obesity and comorbidities that can be tailored to individual needs, enabling people to live healthier lives." Sharon Barr, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca Weight Loss Results In AstraZeneca's VISTA Phase 2b trial , adults living with obesity or overweight plus at least one weight-related condition lost an average of 10.5% of their body weight after 26 weeks on the highest dose of elecoglipron
Upon direct intramuscular injection of pre-formed -synuclein fibrils in the duodenum of ASO mice, investigators report a heightened inflammatory response (IL-6) in the duodenum 7 days post-inoculation (dpi), which likely suggests an early protective response to maintain enteric health (Schafer et al., 1999
Unlike the injectables, it requires daily dosing with strict timing instructions
Standard glutathione supplements often struggle to survive the harsh environment of the digestive tract